Oral pyridoxine during pregnancy: Potential protective effect for cardiovascular malformations

Drugs in R and D

Volumn 5, Issue 5, 2004, Pages 259-269

  Czeizel, Andrew E ^a,c   Puhó, Erzsébet ^a   Bánhidy, Ferenc ^b   Ács, Nándor ^b  

^a FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c NONE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; MULTIVITAMIN; PYRIDOXINE;

ARTICLE; CARDIOVASCULAR MALFORMATION; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONGENITAL MALFORMATION; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FETUS; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; HEALTH SURVEY; HUMAN; HUNGARY; INFANT; INFANT DISEASE; MAJOR CLINICAL STUDY; MOTHER; NEWBORN; NEWBORN DISEASE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TERATOGENICITY;

ADULT; CASE-CONTROL STUDIES; DATA INTERPRETATION, STATISTICAL; DATABASES, FACTUAL; DIETARY SUPPLEMENTS; FEMALE; HEALTH SURVEYS; HUMANS; HUNGARY; INFANT, NEWBORN; ODDS RATIO; PREGNANCY; PYRIDOXINE; RISK ASSESSMENT; SOCIOECONOMIC FACTORS; TERATOGENS; VASCULAR MALFORMATIONS; VITAMINS; YOUNG ADULT;

EID: 7244247378     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200405050-00002     Document Type: Article

References (61)

1. Reynolds RD, Leklen JE, editors. Vitamin B6: its role in health and disease. New York: Alan R. Liss, 1985
2. György P. Investigations of the vitamin B complex: I. the differentiation of lactoflavin and the "rat antipellagra" factor. Biochem J 1935; 29: 741-59
3. 2 and the pellagra-like dermatitis in rats [letter]. Nature 1934; 133: 498
4. 6. Am J Clin Nutr 1971; 24: 1250-4
5. Sauberlich HE. Interaction of vitamin B6 with other nutrients. In: Reynolds RD, Leklen JE, editors. Vitamin B6: its role in health and disease. New York: Alan R. Liss, 1985: 193-217
6. Baker H, Frank O, Danegelis B, et al. Role of placenta in maternal-fetal vitamin transfer in humans. Am J Obstet Gynecol 1981; 141: 792-6
7. Frank O, Walbroehl G, Thompson A, et al. Placental transfer: fetal retention of some vitamins. Am J Clin Nutr 1970; 23: 662-3
8. Hill EP, Longo LD. Dynamics of maternal-fetal nutrient transfer. Fed Proc 1980; 39: 239-44
9. Schenker S, Johnson RF, Mahuren JD, et al. Human placental vitamin B6 (pyridoxal) transport: normal characteristics and effects of ethanol. Am J Physiol 1992; 262: 966-74
10. Bender DA. Vitamin B6 requirements and recommendations. Eur J Clin Nutr 1989; 43: 289-309
11. Reinken L, Dapunt O. Vitamin B6 nutriture during pregnancy. Int J Vitam Nutr Res 1978; 48: 341-7
12. Roepke JL, Kirskey A. Vitamin B6 nutriture during pregnancy and lactation: I. Vitamin B6 intake, levels of the vitamin in biological fluids, and condition of the infant at birth. Am J Clin Nutr 1979; 32: 2249-56
13. National Research Council. Recommended dietary allowances. 10th ed. Washington, DC. National Academy Press, 1989: 262
14. Czeizel AE, Dudás I, Fritz G, et al. The effect of periconceptional multivitamin-mineral supplementation of vertigo, nausea and vomiting in the first trimester of pregnancy. Arch Gynecol Obstet 1992; 251: 181-5
15. 6 deficiency: omphalocele, skeletal and neural defects, and splenic hypoplasia. Science 1970; 169: 1329-30
16. Miller TJ. Cleft palate formation: a role for pyridoxine in the closure of the secondary palate in mice. Teratology 1972; 6: 351-6
17. Schuster K, Bailey LB, Mahan CS. Effect of maternal pyridoxine X HCl supplementation on the vitamin B6 status of mother and infant and on pregnancy outcome. Am J Clin Nutr 1981; 34: 1731-5
18. Roepke JL, Kirskey A. Vitamin B6 nutriture during pregnancy and lactation: II. The effect of long-term use of oral contraceptives. Am J Clin Nutr 1979; 32: 2257-64
19. Brophy MH, Siiteri PK. Pyridoxal phosphate and hypertensive disorders of pregnancy. Am J Obstet Gynecol 1975; 121: 1075-9
20. Hallert C, Öström J, Walan A. Reversal of psychopathology in adult coeliac disease with the aid of pyridoxine (vitamin B6). Scand J Gastroenterol 1983; 18: 299-304
21. Bhagavan HN. Interaction between vitamin B6 and drugs. In: Reynolds RD, Leklem JE, editors. Vitamin B6: its role in health and disease. New York: Alan R. Liss, 1985: 401-15
22. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 5th ed. Baltimore: Williams and Wilkins, 1998
23. Friedman JM, Polifka JE. The effects of drugs on the fetus and nursing infant. Baltimore: Johns Hopkins University Press, 1996
24. Nishimura H, Tanimura T. Clinical aspects of the teratogenicity of drugs. Amsterdam: Experta Medica, 1976
25. Shepard TH. Catalog of teratogenic agents. 9th ed. Baltimore: Johns Hopkins Univ Press, 1998
26. Cohen M, Bendich A. Safety of pyridoxine: a review of human and animal studies. Toxicol Lett 1986; 34: 129-39
27. Joint Food Safety and Standards Group. Survey of dietary supplements containing vitamin B-6. London: Ministry of Agriculture, Fisheries and Food, 1997
28. Collier J. Vitamin B-6: food or medicine. BMJ 1998; 317: 92-3
29. Averback P. Anencephaly associated with megavitamin therapy [letter]. CMAJ 1976; 114: 995
30. Gardner LI, Welsh-Sloan J, Cady RB. Phocomelia in infant whose mothers took large doses of pyridoxine during pregnancy (letter). Lancet 1985; 1: 636
31. Peer L, Bryan W, Stream LP. Induction of cleft palate in mice by cortisone and its reduction by vitamins. J Int Coll Surg 1958; 30: 249-54
32. Yamaguchi T. Effects of riboflavin, pyridoxine and folic acid on the incidence of malformations in the rat caused by hypervitaminosis A. Congenit Anom (Kyoto) 1968; 8: 175-82
33. Yoneda T, Pratt RM. Vitamin B6 reduces cortisone-induced cleft palate in the mouse. Teratology 1982; 26: 255-8
34. Dostal M, Schubert J. Further studies on protective effects of vitamins in cyclophosphamide-induced cleft palate. Int J Oral Maxillofac Surg 1990; 19: 308-11
35. Jacobsson C, Coranstrom G. Effects of vitamin B6 on beta-aminoproprionitrile-induced palatal cleft formation in the rat. Cleft Palate Craniofac J 1997; 34: 95-100
36. 6 therapy. Plast Reconstr Surg 1958; 22: 442-9
37. Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327: 1832-5
38. Czeizel AE. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ 1993; 306: 1645-8
39. Czeizel AE. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 1996; 62: 179-83
40. Czeizel AE, Rockenbauer M, Siffel CS, et al. Description and mission evaluation of the Hungarian case-control surveillance of congenital abnormalities, 1980-1996. Teratology 2001; 63: 176-85
41. Czeizel AE. The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology 1997; 55: 299-305
42. Czeizel AE, Petik D, Vargha P. Validation studies of drug exposures in pregnant women. Pharmacoepidemiol Drug Saf 2003; 12: 409-16
43. Mitchelson F. Pharmacological agents affecting emesis: a review I. Drugs 1992; 43 (3): 295-315
44. Mitchelson F. Pharmacological agents affecting emesis: a review II. Drugs 1992; 43 (4): 443-63
45. Czeizel AE, Mosonyi A. Monitoring of early human fetal development in women exposed to large doses of chemicals. Environ Mol Mutagen 1997; 30: 240-4
46. Czeizel AE. The first trimester concept is outdated (editorial). Congenit Anom 2001; 41: 204
47. Czeizel AE, Sárközi A, Wyszynski DF. Protective effect of hyperemesis gravidarum for nonsydromic oral clefts. Obstet Gynecol 2003; 101: 737-44
48. Wyatt KM, Dimmock PW, Jones PW, et al. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ 1999; 318: 1375-8
49. Rockenbauer M, Olsen J, Czeizel AE, et al. Recall bias in a case-control study on the use of medicine during pregnancy. Epidemiology 2001; 12: 461-6
50. Heionen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Massachusetts: Publishing Sciences Group, 1977
51. Shaw GW, O'Malley CD, Wasserman CR, et al. Maternal periconceptional use of multivitamin and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet 1995; 59: 536-45
52. Botto LD, Khoury MJ, Mulinare J, et al. Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based case-control study. Pediatrics 1996; 98: 911-7
53. Botto LD, Mulinare J, Erickson JD. Occurrence of congenital heart defects in relation to maternal multivitamin use. Am J Epidemiol 2000; 151: 878-84
54. Czeizel AE, Susanszky E. Diet intake and vitamin supplement use of Hungarian women during the preconceptional period. Int J Vitam Nutr Res 1994; 64: 300-5
55. Kapusta L, Haagmans ML, Steegers EA, et al. Congenital heart defects and maternal derangement of homocysteine metabolism. J Pediatr 1999; 135: 773-4
56. Wenstrom KD, Johanning GL, Johnston KE, et al. Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac defects. Am J Obstet Gynec 2001; 184: 806-12
57. Selhub J, Jacques PF, Wilson PWF, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270: 2693-8
58. Koechler KM, Pareo-Tubbeh SL, Lang HC, et al. Some vitamin sources relating to plasma homocysteine provide not only folate but also vitamins B-12 and B-6. Am J Clin Nutr 1997; 127: 1534-5
59. Czeizel AE, Er E, Tóth J. An epidemiological study on undescended testis. J Urol 1981; 126: 524-7
60. 6) during organogenesis. Experientia 1975; 31: 469-70
61. Marathe MR, Thomas GP. Absence of teratogenicity of pyridoxine in Wistar rats. Indian J Physiol Pharmacol 1986; 30: 264-6